215 related articles for article (PubMed ID: 35969278)
1. Pioglitazone enhances proteinuria reduction in complicated pediatric nephrotic syndrome.
Hunley TE; Hidalgo G; Ng KH; Shirai Y; Miura K; Beng HM; Wu Q; Hattori M; Smoyer WE
Pediatr Nephrol; 2023 Apr; 38(4):1127-1138. PubMed ID: 35969278
[TBL] [Abstract][Full Text] [Related]
2. Nephrotic syndrome-associated hypercoagulopathy is alleviated by both pioglitazone and glucocorticoid which target two different nuclear receptors.
Waller AP; Agrawal S; Wolfgang KJ; Kino J; Chanley MA; Smoyer WE; Kerlin BA;
Physiol Rep; 2020 Aug; 8(15):e14515. PubMed ID: 32776495
[TBL] [Abstract][Full Text] [Related]
3. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults.
Tune BM; Mendoza SA
J Am Soc Nephrol; 1997 May; 8(5):824-32. PubMed ID: 9176855
[TBL] [Abstract][Full Text] [Related]
4. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
[TBL] [Abstract][Full Text] [Related]
5. The treatment of idiopathic focal segmental glomerulosclerosis in adults.
Hogan J; Radhakrishnan J
Adv Chronic Kidney Dis; 2014 Sep; 21(5):434-41. PubMed ID: 25168833
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone Enhances the Beneficial Effects of Glucocorticoids in Experimental Nephrotic Syndrome.
Agrawal S; Chanley MA; Westbrook D; Nie X; Kitao T; Guess AJ; Benndorf R; Hidalgo G; Smoyer WE
Sci Rep; 2016 May; 6():24392. PubMed ID: 27142691
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in Children.
Han KH; Kim SH
Biomed Res Int; 2016; 2016():3053706. PubMed ID: 27195285
[TBL] [Abstract][Full Text] [Related]
9. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome.
Carraro M; Caridi G; Bruschi M; Artero M; Bertelli R; Zennaro C; Musante L; Candiano G; Perfumo F; Ghiggeri GM
J Am Soc Nephrol; 2002 Jul; 13(7):1946-52. PubMed ID: 12089392
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis.
Heering P; Braun N; Müllejans R; Ivens K; Zäuner I; Fünfstück R; Keller F; Krämer BK; Schollmeyer P; Risler T; Grabensee B;
Am J Kidney Dis; 2004 Jan; 43(1):10-8. PubMed ID: 14712422
[TBL] [Abstract][Full Text] [Related]
11. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
12. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
Kolonko A; Piecha G; Więcek A
Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154
[TBL] [Abstract][Full Text] [Related]
13. Nephrotic range proteinuria associated with focal segmental glomerulosclerosis reversed with pioglitazone therapy in a patient with Dunnigan type lipodystrophy.
Sharma A; Bourey RE; Edwards JC; Brink DS; Albert SG
Diabetes Res Clin Pract; 2021 Feb; 172():108620. PubMed ID: 33316307
[TBL] [Abstract][Full Text] [Related]
14. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Terada Y; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
Clin Exp Nephrol; 2020 Jun; 24(6):526-540. PubMed ID: 32146646
[TBL] [Abstract][Full Text] [Related]
15. Focal segmental glomerulosclerosis histologic variants and renal outcomes based on nephrotic syndrome, immunosuppression and proteinuria remission.
Kawaguchi T; Imasawa T; Kadomura M; Kitamura H; Maruyama S; Ozeki T; Katafuchi R; Oka K; Isaka Y; Yokoyama H; Sugiyama H; Sato H
Nephrol Dial Transplant; 2022 Aug; 37(9):1679-1690. PubMed ID: 34499164
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of primary FSGS including cluster analysis over a 20-year period.
McDonnell T; Storrar J; Chinnadurai R; Heal C; Chrysochou C; Ritchie J; Rainone F; Poulikakos D; Kalra P; Sinha S
BMC Nephrol; 2023 Dec; 24(1):365. PubMed ID: 38072955
[TBL] [Abstract][Full Text] [Related]
17. Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis.
Fernandez-Fresnedo G; Segarra A; González E; Alexandru S; Delgado R; Ramos N; Egido J; Praga M;
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1317-23. PubMed ID: 19578004
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone, a PPAR-y agonist, as one of the new therapeutic candidates for C3 glomerulopathy.
Balestra E; Barbi E; Ceconi V; Di Maso V; Conversano E; Pennesi M
Pediatr Nephrol; 2024 Jan; 39(1):309-314. PubMed ID: 37493956
[TBL] [Abstract][Full Text] [Related]
19. Minimal change disease and focal segmental glomerulosclerosis in adults: response to steroids and risk of renal failure.
Moura LR; Franco MF; Kirsztajn GM
J Bras Nefrol; 2015; 37(4):475-80. PubMed ID: 26648497
[TBL] [Abstract][Full Text] [Related]
20. A broad clinical spectrum of PLCε1-related kidney disease and intrafamilial variability.
Yılmaz EK; Saygili S; Gulhan B; Canpolat N; Bayazıt AK; Kilic BD; Akıncı N; Benzer M; Goknar N; Tufan AK; Kalyoncu M; Nalcacioglu H; Tekcan D; Yıldız G; Agbas A; Nayır A; Topaloglu R; Caliskan S; Ozaltin F
Pediatr Nephrol; 2022 Aug; 37(8):1855-1866. PubMed ID: 35034193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
